Addressed Problem

BiliSURE addresses the critical problem of delayed and invasive bilirubin measurement in newborns. Traditional methods often involve painful blood tests, causing delays in identifying jaundice. This delay can lead to severe health complications, including brain damage.

Technology

BiliSURE is an innovative non-invasive device that measures neonatal bilirubin levels through the skin’s response to multi-spectrum light. The device consists of a sensor module that emits and detects light signals. When the light interacts with the skin, it reflects and absorbs, revealing bilirubin concentrations. These readings are processed using our proprietary algorithms to provide accurate bilirubin levels in real-time. This eliminates the need for painful blood tests, ensuring timely and accurate jaundice detection. This user-friendly solution enhances neonatal care outcomes while reducing the risk of complications and readmissions.

Societal Impact

BiliSURE’s impact goes beyond accurate measurements; it ensures early detection, timely treatment, and improved quality of life for newborns and their families. It significantly reduces the dependency on highly skilled healthcare professionals for bilirubin measurements, leading to optimized labor allocation and cost savings in healthcare facilities, especially in resource-constrained areas where trained staff may be limited.

Current status

As of November 2024, Medblue Innovations has successfully deployed three Bilisure devices in healthcare facilities across India. These installations have enabled over 1,000 newborns to receive non-invasive jaundice screenings, facilitating early detection and timely intervention. They are actively working to expand their reach and increase the number of installations in the coming months.